Therapy-related Leukemia and Myelodysplasia: Evolving Concepts of Pathogenesis and Treatment

References

• Foucar, K., McKenna, R.W., Bloomfield, CD., Bowers, T.K. and Brunning, R.D. (1979) "Therapy-related leukemia: a panmyelosis", Cancer 43, 1285–1296.
   PubMed Web of Science ®Google Scholar
• Canellos, G.P. (1984) "Therapy-related leukemia: a necessary complication of successful systemic chemotherapy?", J. Clin. Oncol. 2, 1077–1079.
   PubMed Web of Science ®Google Scholar
• Cadman, E.C., Capizzi, R.L. and Bertino, J.R. (1977) "Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases", Cancer 40, 1280–1296.
   PubMed Web of Science ®Google Scholar
• Whang-Peng, J., Knutsen, T., O'Donnell, J.F. and Brereton,H.D. (1979) "Acute non-lymphocytic leukemia and acute myelo-proliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia: cytogenetic studies", Cancer 44, 1592–1600.
   PubMed Web of Science ®Google Scholar
• Bradley, E.C., Schechter, G.P., Matthews, M.J., VVhang-Peng, J., Cohen, M.H., Bunn, P.A., Ihde, D.C. and Minna, J.D. (1982) "Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer", Cancer 49, 221–223.
   PubMed Web of Science ®Google Scholar
• Boice, J.D., Jr., Greene, M.H., Killen, J.Y.Jr.,, Ellenberg, S.S., Keehn, R.J., McFadden, E., Chen, T.T. and Fraumeni, J.F.Jr., (1983) "Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)", N. Engl. J. Med. 309, 1079–1084.
   PubMed Web of Science ®Google Scholar
• Greene, M.H., Young, R.C., Merrill, J.M. and DeVita, V.T. (1983) "Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma", Cancer Res. 43, 1891–1898.
   PubMed Web of Science ®Google Scholar
• Greene, M.H., Harris, E.L., Gershenson, D.M., Malkasian, G.D., Jr., Melton, L.J., 3rd, Dembo, A.J., Bennett, J.M., Moloney, WC. and Boice, J.D.Jr., (1986) "Melphalan may be a more potent leukemogen than cydophosphamide", Ann. Intern. Med. 105, 360–367.
   PubMed Web of Science ®Google Scholar
• Falkson, G., Gelman, R.S., Dreicer, R., Tormey, D.C., Alberts, A.S., Coccia-Portugal, M.A., Rushing, D. and Bennett, J.M. (1989) "Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer", J. Clin. Oncol. 7, 1252–1259.
   PubMed Web of Science ®Google Scholar
• Smith, M.A., Rubinstein, L. and Ungerleider, R.S. (1994) "Therapy-related acute myeloid leukemia following treat-ment with epipodophyllotoxins: estimating the risks", Med. Pediatr. Oncol. 23, 86–98.
   PubMedGoogle Scholar
• Marolleau, J.P., Brice, P., Morel, P and Gisselbrecht, C. (1993) "Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas", J. Clin. Oncol. 11, 590–591.
   PubMed Web of Science ®Google Scholar
• Stone, R.M. (1994) "Myelodysplastic syndrome after auto-logous transplantation for lymphoma: the price of progress", Blood 83, 3437–3440.
   PubMed Web of Science ®Google Scholar
• Micallef, I.N., Lillington, D.M., Apostolidis, J., Amess, J.A., Neat, M., Matthews, J., Clark, T., Foran, J.M., Salam, A., Lister, T.A. and Rohatiner, A.Z. (2000) "Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies", J. Clin. Oncol. 18, 947–955.
   PubMed Web of Science ®Google Scholar
• Hossfeld, D.K., Holland, J.F., Cooper, R.G. and Ellison, R.R. (1975) "Chromosome studies in acute leukemias developing in patients with multiple myeloma", Cancer Res. 35, 2808–2813.
   PubMed Web of Science ®Google Scholar
• Rowley, J.D., Golomb, H.M. and Vardiman, J.W. (1981) "Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease", Blood 58, 759–767.
   PubMed Web of Science ®Google Scholar
• Le Beau, M.M., Albain, KS., Larson, R.A., Vardiman, J.W., Davis, E.M., Blough, R.R., Golomb, H.M. and Rowley, J.D. (1986) "Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7", J. Clin. Oncol. 4, 325–345.
   PubMed Web of Science ®Google Scholar
• Olney, H.J., Mitelman, F., Johansson, B., Mrozek, K., Berger, R. and Rowley, J.D. (2002) "Unique balanced chromosome abnormalities in treatment-related myelodysplastic syn-dromes and acute myeloid leukemia: report from an international workshop", Genes Chromosomes Cancer 33, 413–423.
   PubMed Web of Science ®Google Scholar
• Bloomfield, C.D., Archer, K.J., Mrozek, K., Lillington, D.M., Kaneko, Y., Head, D.R., Dal Cin, P. and Raimondi, S.C. (2002) "11q23 balanced chromosome aberrations in treat-ment-related myelodysplastic syndromes and acute leukemia: report from an international workshop", Genes Chromosomes Cancer 33, 362–378.
   PubMed Web of Science ®Google Scholar
• Mitelman, F., Nilsson, P.C., Brandt, L., Alimena, G., Gastaldi, R. and Dallapiccola, B. (1981) "Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia", Cancer Genet. Cytogenet. 4, 197–214.
   PubMed Web of Science ®Google Scholar
• Dann, E.J. and Rowe, J.M. (2001) "Biology and therapy of secondary leukaemias", Best Pract. Res. Clin. Haematol. 14, 119–137.
   PubMed Web of Science ®Google Scholar
• Quesnel, B., Kantarjian, H., Bjergaard, J.P., Brault, R, Estey, E., Lai, J.L., Tilly, H., Stoppa, A.M., Archimbaud, E., Harousseau, J.L., et al. (1993) "Therapy-related acute myeloid leukemia with 48;21), inv(16), and t(8;16): a report on 25 cases and review of the literature", J. Clin. Oncol. 11, 2370–2379.
   PubMed Web of Science ®Google Scholar
• Andersen, M.K., Larson, R.A., Mauritzson, N., Schnittger, S., Jhanwar, S.C. and Pedersen-Bjergaard, J. (2002) "Balanced chromosome abnormalities inv(16) and 415;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop", Genes Chromosomes Cancer 33, 395–400.
   PubMed Web of Science ®Google Scholar
• Beaumont, M., Sanz, M., Carli, P.M., Maloisel, E, Thomas, X., Detourmignies, L., Guerci, A., Gratecos, N., Rayon, C., San Miguel, J., Odriozola, J., Calm, J.Y., Huguet, E, Vekhof, A., Stamatoulas, A., Dombret, H., Capote, F., Esteve, J., Stoppa, A.M. and Fenaux, P. (2003) "Therapy-related acute promyelocytic leukemia", J. Clin. Oncol. 21,2123–2137.
   PubMed Web of Science ®Google Scholar
• Sagher, D., Karrison, T., Schwartz, J.L., Larson, R., Meier, P. and Strauss, B. (1988) "Low 06-alkylguanine DNA alkyl-transferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leuke-mia", Cancer Res. 48, 3084–3089.
   PubMed Web of Science ®Google Scholar
• Hoyle, C.F., de Bastos, M., Wheatley, K., Sherrington, P.D., Fischer, P.J., Rees, J.K., Gray, R. and Hayhoe, F.G. (1989) "AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial", Br. J. Haematol. 72, 45–53.
   PubMed Web of Science ®Google Scholar
• Ben-Yehuda, D., Krichevsky, S., Caspi, O., Rund, D., Polliack, A., Abeliovich, D., Zelig, O., Yahalom, V., Paltiel, O., Or, R., Peretz, T., Ben-Neriah, S., Yehuda, O. and Rachmilewitz, E.A. (1996) "Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype", Blood 88, 4296–4303.
   PubMed Web of Science ®Google Scholar
• Michieli, M., Michelutti, A., Damiani, D., Pipan, C., Raspadori, D., Lauria, F. and Baccarani, M. (1993) "A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives", Leuk. Lymphoma 9, 255–264.
   PubMed Web of Science ®Google Scholar
• Philpott, N., Mehta, J., Treleaven, J. and Powles, R. (1994) "Idarubicin, high-dose cytarabine and etoposide for remis-sion induction in therapy-related acute myeloid leukemia", Leuk. Lymphoma 15, 127–130.
   PubMed Web of Science ®Google Scholar
• Mehta, J., Powles, R., Singhal, S., Horton, C., Hamblin, M., Zomas, A., Saso, R., Prendiville, J., Glynne, R, Allford, S., Mackay, H. and Treleaven, J. (1996) "Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia", Semin. Hematol. 33, 18–23.
   PubMed Web of Science ®Google Scholar
• Gardin, C., Chaibi, P., de Revel, T., Rousselot, R, Turlure, R, Miclea, J.M., Nedellec, G. and Dombret, H. (1997) "Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Reflexion en Hematologie", Leukemia 11, 16–21.
   PubMed Web of Science ®Google Scholar
• Ganser, A., Heil, G., Seipelt, G., Hofmann, W., Fischer, J.T., Langer, W., Brockhaus, W., Kolbe, K., Ittel, T.H., Brack, N., Fuhr, HG., Knuth, R, Hoffken, K., Bergmann, L. and Hoelzer, D. (2000) "Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)", Ann. Hematol. 79, 30–35.
   PubMed Web of Science ®Google Scholar
• Keating, M.J., Estey, E., O'Brien, S., Kantarjian, H., Robertson, L.E. and Plunkett, W. (1994) "Clinical experi-ence with fludarabine in leukaemia", Drugs 47\(Suppl 6), 39–49.
   PubMedGoogle Scholar
• Clavio, M., Carrara, R, Miglino, M., Pierri, I., Canepa, L., Balleari, E., Gatti, AM., Cerri, R., Celesti, L., Vallebella, E., Sessarego, M., Patrone, E, Ghio, R., Damasio, E. and Gobbi, M. (1996) "High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia", Haematologica 81, 513–520.
   PubMed Web of Science ®Google Scholar
• Parker, J.E., Pagliuca, A., Mijovic, A., Cullis, J.O., Czepulkowski, B., Rassam, S.M., Samaratunga, I.R., Grace, R., Gover, RA. and Mufti, G.J. (1997) "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia", Br. J. Haematol. 99, 939–944.
   PubMed Web of Science ®Google Scholar
• Saito, K., Nakamura, Y, Aoyagi, M., Waga, K., Yamamoto, K., Aoyagi, A., Inoue, E, Arai, Y, Tadokoro, J., Handa, T., Tsurumi, S., Arai, H., Kawagoe, Y, Gunnji, H., Kitsukawa, Y., Takahashi, W. and Furusawa, S. (2000) "Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelo-genous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation", Int. J. Hematol. 71, 238–244.
   PubMed Web of Science ®Google Scholar
• Denzlinger, C., Bowen, D., Benz, D., Gelly, K., Brugger, W. and Kanz, L. (2000) "Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia", Br. J. Haematol. 108, 93–95.
   PubMed Web of Science ®Google Scholar
• Kerr, R., Cunningham, J. and Bowen, D.T. (2000) "Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyo-types", Leukemia 14, 953.
   PubMed Web of Science ®Google Scholar
• Leone, G., Teofili, L., Voso, M.T. and Lubbert, M. (2002) "DNA methylation and demethylating drugs in myelodys-plastic syndromes and secondary leukemias", Haematologica 87, 1324–1341.
   PubMed Web of Science ®Google Scholar
• Silverman, L.R., Demakos, E.P., Peterson, B.L., Kornblith, A.B., Holland, J.C., Odchimar-Reissig, R., Stone, R.M., Nelson, D., Powell, B.L., DeCastro, C.M., Ellerton, J., Larson, R.A., Schiffer, C.A. and Holland, J.F. (2002) "Randomized con-trolled trial of azacitidine in patients with the myelodys-plastic syndrome: a study of the cancer and leukemia group B", J. Clin. Oncol. 20, 2429–2440.
   PubMed Web of Science ®Google Scholar
• Kornblith, A.B., Herndon, 2nd, I.E., Silverman, L.R, Demakos, E.P., Odchimar-Reissig, R., Holland, J.F., Powell, B.L., DeCastro, C., Ellerton, J., Larson, R.A., Schiffer, CA. and Holland, J.C. (2002) "Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase DI trial: a Cancer and Leukemia Group B study", J. Clin. Oncol. 20, 2441–2452.
   PubMed Web of Science ®Google Scholar
• Lubbert, M., Wijermans, P., Kunzmann, R., Verhoef, G., Bosly, A., Ravoet, C., Andre, M. and Ferrant, A. (2001) "Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine", Br. J. Haematol. 114,349–357.
   PubMed Web of Science ®Google Scholar
• Carella, A.M., Dana, A., Lerma, E., Podesta, M., Benvenuto, E, Chimirri, F., Parodi, C., Sessarego, M., Prencipe, E. and Frassoni, E (1996) "In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia", Br. J. Haematol. 95, 127–130.
   PubMed Web of Science ®Google Scholar
• De Witte, T., Van Biezen, A., Hermans, J., Labopin, M., Runde, V., Or, R., Meloni, G., Mauri, S.B., Carella, A., Apperley, J., Gratwohl, A. and Laporte, J.P. (1997) "Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation", Blood 90, 3853–3857.
   PubMed Web of Science ®Google Scholar
• Schiller, G., Lee, M., Paquette, R., Sawyers, C., Khoubian, F. and Territo, M. (1999) "Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with secondary acute myelogenous leukemia in first remission", Leuk. Lymphoma 33, 475–484.
   PubMed Web of Science ®Google Scholar
• Anderson, J.E., Appelbaum, ER., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., et al. (1993) "Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome", Blood 82, 677–681.
   PubMed Web of Science ®Google Scholar
• de Witte, T., Oosterveld, M., Span, B., Muus, P. and Schattenberg, A. (2002) "Stem cell transplantation for leukemias following myelodysplastic syndromes or second-ary to cytotoxic therapy", Rev. Clin. Exp. Hematol. 6, 72–85, discussion 86–77.
   PubMedGoogle Scholar
• Yakoub-Agha, I., de La Salmoniere, P., Ribaud, P., Sutton, L., Wattel, E., Kuentz, M., Jouet, J.P., Marit, G., Milpied, N., Deconinck, E., Gratecos, N., Leporrier, M., Chabbert, I., Caillot, D., Damaj, G., Dauriac, C., Dreyfus, E, Francois, S., Molina, L., Tanguy, M.L., Chevret, S. and Gluckman, E. (2000) "Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation", J. Clin. Oncol. 18, 963–971.
   PubMed Web of Science ®Google Scholar
• Witherspoon, R.P. and Deeg, H.J. (1999) "Allogeneic bone marrow transplantation for secondary leukemia or myelo-dysplasia", Haematologica 84, 1085–1087.
   PubMed Web of Science ®Google Scholar
• Garrido, S.M., Bryant, E. and Appelbaum, F.R. (2000) "Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities", Leuk. Res. 24, 481–486.
   PubMed Web of Science ®Google Scholar
• Anderson, J.E., Gooley, T.A., Schoch, G., Anasetti, C., Bensinger, WI., Clift, R.A., Hansen, J.A., Sanders, J.E., Storb, R. and Appelbaum, ER. (1997) "Stem cell transplan-tation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy", Blood 89, 2578–2585.
   PubMed Web of Science ®Google Scholar
• Cesaro, S., Messina, C., Rosolen, A., Putti, M.C., Sainati, L., Destro, R., Gazzola, M.V., Varotto, S., De Silvestro, G., Scarzello, G., Spinelli, M., Pinon, M. and Zanesco, L. (1999) "Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease: a case report", Bone Marrow Transplant. 23, 625–628.
   PubMed Web of Science ®Google Scholar
• Spitzer, T.R., McAfee, S., Sackstein, R., Colby, C., Toh, H.C., Multani, P., Saidman, S., Weyouth, D.W., Preffer, F., Poliquin, C., Foley, A., Cox, B., Andrews, D., Sachs, D.H. and Sykes, M. (2000) "Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies", Biol. Blood Marrow Transplant. 6, 309–320.
   PubMed Web of Science ®Google Scholar
• Slavin, S., Nagler, A., Shapira, M.Y., Aker, M., Gabriel, C. and Or, R. (2002) "Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplan-tation", J. Clin. Immunol. 22, 64–69.
   PubMed Web of Science ®Google Scholar
• Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D. and Parker, J. (2003) "Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes", Br. J. Haematol. 120, 187–200.
   PubMed Web of Science ®Google Scholar
• Hellstrom-Lindberg, E., Gulbrandsen, N., Lindberg, G., Ahlgren, T., Dahl, I.M., Dybedal, I., Grimfors, G., Hesse-Sundin, E., Hjorth, M., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Oberg, G., Porwit-MacDonald, A., Radlund, A., Samuelsson, J., Tangen, J.M., Winquist, I. and Wisloff, F. (2003) "A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life", Br. J. Haematol. 120, 1037–1046.
   PubMed Web of Science ®Google Scholar